Burjeel Holdings, a leading super-specialty healthcare group in the GCC listed on the Abu Dhabi Securities Exchange, priced its inaugural USD 500 million Regulation S 5-year senior unsecured Sukuk offering due 2031 under its newly established USD 1.5 billion Senior Unsecured Sukuk Programme.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260625449702/en/

Burjeel Holdings’ inaugural Sukuk was priced at a 7.000 % profit rate and a yield of 7.125% (Photo: AETOSWire)

The offering attracted significant demand from high-quality international and regional investors, with the orderbook peaking at USD 1.6 billion, representing 3.2x oversubscription. The strength of the orderbook enabled Burjeel to tighten pricing from initial price thoughts in the mid-7% area, with the Sukuk priced at a 7.000% profit rate and a yield of 7.125%, representing the lowest 5-year yield by a GCC-based private non-investment grade corporate issuer since 2020.

International investors accounted for 61% of the final allocation, led by the UK (34%) and US Offshore investors (24%), alongside strong GCC participation of 39%, highlighting global confidence in Burjeel and the UAE's capital markets.

Rated BB+ by S&P Global Ratings and Ba2 by Moody's Ratings, the transaction marks the first Sukuk offering from a MENA healthcare provider since 2018 and the first UAE corporate offering since recent regional developments.

Net proceeds will be used in line with the offering documents, including refinancing existing debt and supporting the Group's strategic priorities, strengthening Burjeel's financial flexibility and long-term capital structure.

Dr. Shamsheer Vayalil, Chairman and CEO, said: “The strong demand for our inaugural Sukuk reflects investor recognition of Burjeel’s strategy, credit fundamentals, and ability to deliver sustainable growth. With strong international participation, this transaction broadens our access to global capital markets and provides greater financial flexibility to advance our strategic priorities, including investments in advanced clinical care, research, medical education, and AI-enabled healthcare innovation, as we work to power the next generation of healthcare.

The Sukuk is admitted to trading on the London Stock Exchange’s International Securities Market, subject to customary closing conditions.

Citi, Emirates NBD Capital and FAB acted as Joint Global Coordinators. Emirates NBD Capital and FAB also acted as Sukuk Structuring Agents. ADCB, ADIB, Dubai Islamic Bank, RAKBANK and Sharjah Islamic Bank acted as Joint Lead Managers and Bookrunners.

About Burjeel Holdings

Founded in 2007, Burjeel Holdings is a leading super-specialty healthcare services provider in the UAE and Oman, and it operates a growing specialized healthcare segment in Saudi Arabia.

*Source: AETOSWire

View source version on businesswire.com: https://www.businesswire.com/news/home/20260625449702/en/

Salam Shehady
sshehady@apcoworldwide.com

Logo

Images

Tags

More Like This

PureHealth IPO fully subscribed on first day

Burjeel Holdings Oncology Conference Marks 10 Years, Focusing on Equitable Solutions for Cancer Care

Burjeel Holdings and Response Plus Medical launch $1mn Human Energy Health and Wellbeing Award

PureHealth Delivers Strong H1 2025 Results with AED 13.6 Billion in Revenue and AED 1.03 Billion in Net Profit

PureHealth shares settled a staggering 76% above listing price in Abu Dhabi trading debut

Estithmar Holding Lists the First Corporate Sukuk in Qatari Riyals on London Stock Exchange

PureHealth Reports USD 137.6 Million Net Profit and USD 308.5 Million EBITDA for First Quarter 2025

PureHealth Reports Record Revenue of AED 25.8 Billion and 78% Net Profit Growth to AED 1.7 Billion